Htlv-1-associated Myelopathy
📧 Sign up to get email alerts when something new happens for Htlv-1-associated Myelopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Rituximab for HTLV-1-associated Myelopathy [Phase 2]
Phase 2 clinical trial investigating rituximab for HTLV-1-associated myelopathy.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM) [Phase 3]
Phase 3 trial of KW-0761 for HTLV-1 Associated Myelopathy was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) [Phase 2, Phase 3]
Phase 2/3 trial updates for ciclosporin in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) have completed with results p…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) [Phase 3]
A Phase 3 clinical trial evaluating valproic acid for Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) has completed. The…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Evaluation of the MP Diagnostics HTLV Blot 2.4
Clinical trial update evaluating the MP Diagnostics HTLV Blot 2.4 diagnostic test for HTLV-1/HTLV-2 infections; current status is UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-07-22Clinical Trial Update: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating tamibarotene for HTLV-1-associated myelopathy (HAM/TSP). The current status and results have not been …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) [Phase 2]
Phase 2 trial evaluating recombinant human interferon beta-1a (Avonex) for HTLV-1-associated myelopathy has completed; the snippet does not …
-
CLINICAL_TRIALS trial_result · 2007-08-22Clinical Trial Update: Safety and Efficiency Study of Valproic Acid In HAM/TSP [NA]
This clinical trial evaluated the safety and efficacy of valproic acid in HTLV-1-associated myelopathy (HAM/TSP) and has been terminated.